相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of prostate cancer detection rate at targeted biopsy of hub and spoke centers mpMRI: experience matters
Matteo Droghetti et al.
MINERVA UROLOGY AND NEPHROLOGY (2023)
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
Lars Bjornebo et al.
JAMA ONCOLOGY (2022)
The future direction of imaging in prostate cancer: MRI with or without contrast injection
Martina Pecoraro et al.
ANDROLOGY (2021)
Influence of 5-Alpha Reductase Inhibitors on Prostate Cancer Detection with Magnetic Resonance Imaging: A Matched Cohort Study
Andrei S. Purysko et al.
JOURNAL OF UROLOGY (2021)
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database
Ugo Giovanni Falagario et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials)
Ileana Montoya Perez et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators
Ugo Giovanni Falagario et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2
Baris Turkbey et al.
EUROPEAN UROLOGY (2019)
Long-Term Effects of Finasteride on Prostate Cancer Mortality
Phyllis J. Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial
Ivan Jambor et al.
PLOS MEDICINE (2019)
The effect of 5 alpha-reductase inhibitor therapy on prostate cancer detection in the era of multi-parametric magnetic resonance imaging
Jung Kwon Kim et al.
SCIENTIFIC REPORTS (2019)
Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naive Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study
Marloes van der Leest et al.
EUROPEAN UROLOGY (2019)
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
Olivier Rouviere et al.
LANCET ONCOLOGY (2019)
Prostate cancer detection using quantitative T2 and T2-weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance
Francesco Giganti et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2018)
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
V Kasivisvanathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial
Javier Hernandez et al.
PLOS ONE (2018)
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
Francesco Giganti et al.
EUROPEAN RADIOLOGY (2017)
Novel Biparametric MRI and Targeted Biopsy Improves Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer (IMPROD Trial)
Ivan Jambor et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2017)
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Hashim U. Ahmed et al.
LANCET (2017)
Improved multiparametric MRI discrimination between low-risk prostate cancer and benign tissues in a small cohort of 5-reductase inhibitor treated individuals as compared with an untreated cohort
Olga Starobinets et al.
NMR IN BIOMEDICINE (2017)
Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use
Jelle O. Barentsz et al.
EUROPEAN UROLOGY (2016)
MAPPED study design: A 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging
N. L. Robertson et al.
CONTEMPORARY CLINICAL TRIALS (2013)
Long-Term Survival of Participants in the Prostate Cancer Prevention Trial
Ian M. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
Marc R. Theoret et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of Dutasteride on the Risk of Prostate Cancer.
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Finasteride and high-grade prostate cancer in the prostate cancer prevention trial
M. Scott Lucia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Effect of finasteride on the sensitivity of PSA for detecting prostate cancer
Ian M. Thompson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Long-term effects of finasteride on prostate specific antigen levels: Results from the Prostate Cancer Prevention Trial
RD Etzioni et al.
JOURNAL OF UROLOGY (2005)
The influence of finasteride on the development of prostate cancer
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
